Grade I = good prognosis; grade III = bad prognosis.
LCIS
- Tubule formation = happy sign.
- Mitotic count per high-power field.
- Nuclear size and pleomorphism (enlargement and variation are bad).
DCIS
90% of DCIS are identified on mammography as suspicious calcifications, linear, clustered, segmental, focal, or mixed distribution. DCIS is divided into comedo (i.e. cribriform, micropapillary, solid) and noncomedo subtypes, which prognosticates on the likelihood of progression or local recurrence:
| DCIS Characteristic | Comedo | Noncomedo |
| Nuclear grade | High | Low |
| ER | - | + |
| HER2 overexpression | Present | Absent |
| Distribution | Continuous | Multifocal |
| Necrosis | Present | Absent |
| Local recurrence | High | Low |
| Prognosis | Worse | Better |
LCIS
Arises from the terminal duct apparatus and shows a diffuse distribution throughout the breast, which explains its presentation as a nonpalpable mass in most cases.
Infiltrating ductal carcinoma
The most commonly diagnosed breast tumour (75%). Has a tendency to metastasise via lymphatics. Has no specific histologic characteristics other than invasion through the basement membrane. DCIS is a frequently associated finding on pathologic examination. Typically metastasises to axillary LNs first.
Infiltrating lobular carcinoma
Much lower incidence (15%). Characterised histologically by the 'Indian file' arrangement of small tumour cells. Like ductal carcinoma, infiltrating lobular carcinoma typically metastasises to axillary LNs first. However, it also has a tendency to be more multifocal. Despite this, the prognosis is comparable to that of ductal carcinoma.
Medullary carcinoma
Relatively uncommon (5%). Generally occurs in younger women. Most present with a bulky palpable mass with axillary lymphadenopathy. Diagnosis depends on a histological triad:
- Sheets of anaplastic tumour cells with scant stroma.
- Moderate or marked stromal lymphoid infiltrate.
- Histological circumscription or a pushing border.
DCIS may be observed in the surrounding normal tissues. Typically ER-, PR- and HER2-. TP53 is commonly mutated.
Mucinous carcinoma
Rather rare (fewer than 5%). Usually presents in the 60s as a palpable mass or appears mammographically.
Excellent prognosis (80% 10-year survival).
Mucin production is the histological hallmark with 2 main forms, type A and B, with AB lesions possessing features of both. Type A represents the classic variety with larger quantities of extracellular mucin, whereas type B shows endocrine differentiation.
DCIS is not a frequent occurrence, although it may be found. Most are ER+ and PR+. HER2 overexpression in rare. These carcinomas predominantly express glycoproteins MUC2 and MUC6.
Tubular carcinoma
1-2%. Single layer of epithelial cells with low-grade nuclei and apical cytoplasmic snoutings arranged in well-formed tubules and glands. L
ow incidence of LN involvement and very high overall survival rate. Because of its good prognosis, patients are often treated only with breast-conserving surgery and local radiation therapy.
Papillary carcinoma
1-2%. Women older than 60y. Centrally located in the breast and can present as a bloody nipple discharge. Strongly ER+ and PR+.
2 common types: Cystic (non-invasive) and micropapillary ductal carcinoma (invasive). The cystic type has a low mitotic activity, which results in a more indolent course and good prognosis. Micropapillary ductal carcinoma has a more aggressive phenotype, even though 70% are ER+. LN metastasis is seen frequently.
Metaplastic breast cancer (MBC)
1%. Older women. Higher incidence in blacks. Combination of adenocarcinoma + mesenchymal and epithelial components.
A wide variety of histologic patterns including:
- Spindle cell carcinoma
- Carcinosarcoma
- Squamous cell carcinoma of ductal origin
- Adenosquamous carcinoma, etc.
The diverse group of malignancies is identified as a single entity based on a similarity in clinical behavious. When compared with infiltrating ductal carcinomam MBC tumours are larger, more rapidly growing, commonly LN-negative, and typically ER-, PR-, HER-.
Mammary Paget disease
Relatively rare (1-4%). Peak incidence in the 50s.
This adenocarcinoma is localised within the epidermis of the nipple-areola complex and composed of the histologic hallmark Paget cells within the basement membrane. Paget cells are large, pale epithelial cells with hyperchromatic, atypical nuclei, dispersed between the keratinocytes singly or as a cluster of cells.
Lesions are predominantly unilateral, developing insidiously as a scaly, fissured, oozing, or erythematous nipple-areola complex. Retraction or ulceration of the nipple is often noted, along with symptoms of itching, tingling, burning or pain.